+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Murine model of invasive aspergillosis



Murine model of invasive aspergillosis



Methods in Molecular Medicine 118: 129-142



This chapter describes a murine model of invasive aspergillosis suitable for basic and translational studies of invasive pulmonary aspergillosis and highlights experimental variables that affect the course and reproducibility of infection.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 004243789

Download citation: RISBibTeXText

PMID: 15888939

DOI: 10.1385/1-59259-943-5:129


Related references

A nonlethal murine cutaneous model of invasive aspergillosis. Methods in Molecular Biology 845: 569-582, 2012

Novel inhalational murine model of invasive pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 48(5): 1908-1911, 2004

Invasive aspergillosis associated with prolonged leukopenia in a murine model. Journal de Mycologie Medicale 9(4): 221-225, 1999

Standardization of an experimental murine model of invasive pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 50(10): 3501-3503, 2006

Activity of d0870 in a non immunocompromised murine model of invasive aspergillosis. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 285, 1992

In vivo pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 445, 2003

Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis. Medical Mycology 49(8): 834-847, 2011

Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 50(10): 3464-3466, 2006

Evaluation of a PCR and culture assays to detect Aspergillus DNA in a murine model of invasive aspergillosis. Blood 98(11 Part 1): 388a-389a, 2001

Efficacy and pharmacodynamics of flucytosine monotherapy in a nonneutropenic murine model of invasive aspergillosis. Antimicrobial Agents and ChemoTherapy 49(10): 4220-4226, 2005

Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clinical and Experimental Immunology 148(2): 382-389, 2007

Dose-response relationships of three amphotericin B formulations in a non-neutropenic murine model of invasive aspergillosis. Medical Mycology 47(8): 802-807, 2009

Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infection and Immunity 69(4): 2728-2731, 2001

Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection. Journal of Clinical Microbiology 34(6): 1433-1439, 1996